Numobag offers a topical hyperbaric oxygen therapy system designed to enhance wound healing by delivering high-pressure oxygen directly to the affected area. This therapy accelerates tissue repair and reduces the risk of infection, addressing the challenges associated with slow-healing wounds.
Funding
$450K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Chronic wounds, such as diabetic ulcers and pressure sores, often suffer from impaired oxygen supply, hindering the natural healing process. Traditional hyperbaric oxygen therapy requires patients to enter a specialized chamber, which can be inconvenient, costly, and inaccessible for many individuals. This lack of localized oxygen delivery prolongs healing times and increases the risk of complications.
Solution
Numobag provides a topical hyperbaric oxygen therapy system designed to deliver concentrated oxygen directly to wounds, promoting faster and more effective healing. The system utilizes a specialized bag that encloses the wound and creates a localized, high-pressure oxygen environment. This targeted approach enhances tissue oxygenation, stimulates cell regeneration, and reduces the risk of infection. By delivering oxygen directly to the affected area, Numobag accelerates the healing process and improves patient outcomes.
Target Audience
The primary target audience includes patients with chronic wounds, such as diabetic ulcers, pressure sores, and surgical wounds, as well as healthcare providers in wound care clinics, hospitals, and home healthcare settings.
Features
- Topical hyperbaric chamber that conforms to the wound site
- Adjustable pressure settings to optimize oxygen delivery
- Portable and easy-to-use design for convenient application
- Integrated oxygen concentrator for a self-contained system
- Disposable bags to maintain sterility and prevent cross-contamination